Control infant formula
OtherReady to feed infant formula, feed ad libitum
NCT Number: NCT04105686
This is a randomized, multicenter, controlled, double-blind, parallel study to evaluate growth and tolerance of healthy term infants fed milk-based infant formulas.
Looking for future studies?
Notify MeUp to 14 day
All sexes
Interventional
Not applicable
Central Research Associates, Birmingham, Alabama, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ready to feed infant formula, feed ad libitum
Ready to feed infant formula, feed ad libitum
Time frame: Day of life 14 to Day of life 119
Weight gain per day
Time frame: Study Day 1 to Day of life 119
Parent completed diary
Time frame: Study Day 1 to Day of life 119
Parent completed diary
Time frame: Day of life 14 to Day of life 119
Length gain per day
Time frame: Day of life 14 to Day of life 119
HC gain per day
Time frame: Study Day 1 to Day of Life 119
Parent reported lifestyle and illness questions
Time frame: Exit or Day of life 119
Parent completed questionnaire; 16, 5-point Likert scale questions, scaled in the negative direction
Time frame: Exit or Day of life 42 to Day of life 119
Parent completed questionnaire; 22 questions with 5-point Likert scale questions, scaled in the negative direction
Time frame: Exit or Day of life 119
Parent completed questionnaire; 12 questions with 5-point Likert scale questions scaled in the negative direction
Abbott Nutrition
Industry
Growth and Tolerance of Young Infants Fed Milk-Based Infant Formula With Oligosaccharides
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01808105
Growth and Tolerance
Birmingham, Alabama, United States
View Trial DetailsNCT02006992
Growth and Tolerance
Little Rock, Arkansas, United States
View Trial Details